Log in to save to my catalogue

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2577920834

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

SARS-CoV-2 Beta variant of concern (VOC) resists neutralization by major classes of antibodies from non-VOC COVID-19 patients and vaccinated individuals. Here, serum of Beta variant infected patients revealed reduced cross-neutralization of non-VOC virus. From these patients, we isolated Beta-specific and cross-reactive receptor-binding domain (RBD...

Alternative Titles

Full title

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2577920834

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2577920834

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2021.09.30.462420